Biogen drug slows progress of motor neurone disease in landmark trial Tofersen targets a defective gene that causes about 2% of cases of MND, also known as amyotrophic lateral sclerosis
from UK homepage
via By Anand Gupta
from UK homepage
via By Anand Gupta
Tags
Biogen drug slows progress of motor neurone disease in landmark trial
Finance and Accounting Blogs
Financial Blogs
Mr. Anand Gupta
the anand gupta show
UK homepage